MAPK3 and endometrium adenocarcinoma: Collectively, the present study showed that metformin inhibits cell proliferation and the EMT, as well as the 17β-estradiol-induced proliferation and EMT in endometrial adenocarcinoma cells through βKlotho-related ERK1/2 signaling and AMPKα signaling.